Rybelsus belongs to a class of drugs known as GLP-1 receptor agonists. It is also known as an incretin mimetic.
Rybelsus works by replicating the effects of the body's own incretin hormones, which help manage blood sugar levels, particularly after a meal.
Incretin hormones are peptides secreted from the stomach when food is consumed. They also promote insulin production in response to elevated blood glucose levels. GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) are two incretin hormones.